Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...

A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn ...

"Our Flow Cytometry MRD for Myeloma test harnesses cutting-edge science and technology to deliver ultrasensitive insights from a noninvasive blood test, thereby improving care and value for patients ...

This eBook explores quality and analytics in the contexts of laboratory digitization, raw-materials monitoring, and modern ...

Philip Awadalla has been studying population genetics for decades, and is still amazed at what scientists have learned from comparing genomes at scale. “There have been massive advancements in our ...

The U.S. Food and Drug Administration (FDA) has accepted a new drug application for iberdomide combined with Darzalex ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...

For more than a century, scientists and conservationists have tried to bring back the American chestnut, a tree once so ...

Scientists have uncovered new DNA-binding proteins from some of the most extreme environments on Earth and shown that they ...